Acuta Capital Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-297,035
| Closed | -$4.31M | – | 53 |
|
|
2023
Q3 | $4.31M | Sell |
297,035
-2,806
| -0.9% | -$40.7K | 2.89% | 13 |
|
|
2023
Q2 | $6.28M | Sell |
299,841
-30,159
| -9% | -$631K | 4.25% | 5 |
|
|
2023
Q1 | $6.97M | Buy |
330,000
+5,386
| +2% | +$114K | 5.13% | 6 |
|
|
2022
Q4 | $8.26M | Hold |
324,614
| – | – | 5.08% | 7 |
|
|
2022
Q3 | $7.8M | Buy |
324,614
+119,611
| +58% | +$2.87M | 3.36% | 8 |
|
|
2022
Q2 | $3.94M | Sell |
205,003
-1,123
| -0.5% | -$21.6K | 2.2% | 15 |
|
|
2022
Q1 | $3.58M | Hold |
206,126
| – | – | 1.67% | 23 |
|
|
2021
Q4 | $4.51M | Hold |
206,126
| – | – | 1.9% | 16 |
|
|
2021
Q3 | $3.94M | Hold |
206,126
| – | – | 1.39% | 21 |
|
|
2021
Q2 | $3.54M | Sell |
206,126
-49,054
| -19% | -$842K | 1.41% | 24 |
|
|
2021
Q1 | $5.71M | Sell |
255,180
-210,320
| -45% | -$4.7M | 2.06% | 22 |
|
|
2020
Q4 | $10.4M | Buy |
465,500
+224,756
| +93% | +$5M | 2.82% | 13 |
|
|
2020
Q3 | $3.55M | Hold |
240,744
| – | – | 0.96% | 30 |
|
|
2020
Q2 | $3.57M | Buy |
+240,744
| New | +$3.57M | 1.03% | 33 |
|